Oxygen therapy with high-flow nasal cannulas in children with acute bronchiolitis

Zielińska, Anna; Jassem-Bobowicz, Joanna Maria; Kwiatkowska, J

doi:10.5603/ait.2019.0010

Cited by 7 publications

(8 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

Section: Oxígeno (O2)unclassified

“…No existe consenso sobre el nivel de SpO2 a alcanzar con el soporte de O2 administrado mediante cánula nasal o mascarilla (28,29). En el Reino Unido, se suele administrar O2 para alcanzar una SpO2 del 92-95%, mientras que la AAP recomienda mantener la SpO2 en al menos 90% (28). Sin embargo, estudios observacionales sugieren que una SpO2 de 90% versus 94% reduce significativamente la duración de la estadía hospitalaria, por ello las guías de la AAP recomiendan un nivel reducido de SpO2 a medida que los lactantes mejoran.…”

Section: Oxígeno (O2)unclassified

“…El CPAP (4-8 cm H2O) reduce la PCO2 y dificultad respiratoria en forma rápida y segura, aunque no ha demostrado que reduzca la necesidad de ventilación invasiva (64,65). El uso de cánulas nasales de alto flujo humidificadas (HFNC) es una alternativa al uso del CPAP (66). Actúa incrementando la presión faríngea y reduciendo el trabajo respiratorio, disminuyendo la necesidad de intubación (67).…”

Section: Ventilación No Invasivaunclassified

See 2 more Smart Citations

Actualizacion De La Bronquiolitis Aguda

Vega-Briceño¹

2021

Neumol Pediatr

View full text Add to dashboard Cite

La bronquiolitis aguda es una condición respiratoria frecuente en los niños menores de 2 años. Representa la principal causa de hospitalización infantil y se caracteriza por la presencia de sibilancias asociada a signos de una infección respiratoria alta. El agente etiológico más común es el virus respiratorio sincicial. Existe una falta de consenso con respecto a su definición clínica; y por ello, su tratamiento varía en todo el mundo. El diagnóstico es clínico, sin necesidad de emplear laboratorio o imágenes en forma rutinaria. Diversas revisiones han demostrado que los broncodilatadores, adrenalina, corticoides y antibióticos, entre otros, carecen de eficacia por lo que no se sugiere su empleo. El tratamiento sigue siendo de soporte, mediante la administración de oxígeno y manteniendo una adecuada hidratación. Cuando no se logra disminuir el trabajo respiratorio o corregir la hipoxemia se puede utilizar la presión positiva en la vía aérea para prevenir y controlar la insuficiencia respiratoria. Este artículo desarrolla una breve revisión de las principales características clínicas, epidemiológicas, radiológicas, así como algunos de los diferentes tratamientos publicados en las últimas dos décadas.

show abstract

Section: Oxígeno (O2)unclassified

Section: Ventilación No Invasivaunclassified

See 1 more Smart Citation

Actualizacion De La Bronquiolitis Aguda

Vega-Briceño¹

2021

Neumol Pediatr

View full text Add to dashboard Cite

show abstract

“…High-flow nasal cannula (HFNC) oxygen is a noninvasive ventilation system that was introduced as an alternative to CPAP (continuous positive airway pressure), with a marked increase in its use in pediatric care settings [1][2][3]. In children with bronchiolitis, HFNC has been used as an alternative to CPAP and mechanical ventilation, with adequate tolerance [4][5][6][7].…”

Section: Introductionmentioning

confidence: 99%

The cost-utility of early use of high-flow nasal cannula in bronchiolitis

2021

View full text Add to dashboard Cite

Background High-flow nasal cannula (HFNC) oxygen is a non-invasive ventilation system that was introduced as an alternative to CPAP (continuous positive airway pressure), with a marked increase in its use in pediatric care settings. This study aimed to evaluate the cost-effectiveness of early use of HFNC compared to oxygen by nasal cannula in an infant with bronchiolitis in the emergency setting. Methods A decision tree model was used to estimate the cost-effectiveness of HFNC compared with oxygen by nasal cannula (control strategy) in an infant with bronchiolitis in the emergency setting. Cost data were obtained from a retrospective study on bronchiolitis from tertiary centers in Rionegro, Colombia, while utilities were collected from the literature. Results The QALYs per patient calculated in the base-case model were 0.9141 (95% CI 0.913–0.915) in the HFNC and 0.9105 (95% CI 0.910–0.911) in control group. The cost per patient was US$368 (95% CI US$ 323–411) in HFNC and US$441 (95% CI US$ 384–498) per patient in the control group. Conclusions HFNC was cost-effective HFNC compared to oxygen by nasal cannula in an infant with bronchiolitis in the emergency setting. The use of this technology in emergency settings will allow a more efficient use of resources, especially in low-resource countries with high prevalence of bronchiolitis .

show abstract

“…High-ow nasal cannula (HFNC) oxygen is a non-invasive ventilation system that was introduced as an alternative to CPAP (continuous positive airway pressure), with a marked increase in its use in pediatric care settings (1)(2)(3). In children with bronchiolitis, HFNC has been used as an alternative to CPAP and mechanical ventilation, with adequate tolerance (4-7).…”

Section: Introductionmentioning

confidence: 99%

The Cost‑utility of Early use of High-flow Nasal Cannula in Bronchiolitis

Rodriguez

Acuña‐Cordero

Rodríguez‐Martínez

2020

Preprint

View full text Add to dashboard Cite

Background: High-flow nasal cannula (HFNC) oxygen is a non-invasive ventilation system that was introduced as an alternative to CPAP (continuous positive airway pressure), with a marked increase in its use in pediatric care settings .This study aimed to evaluate the cost-effectiveness of early use of HFNC compared to oxygen by nasal cannula in an infant with bronchiolitis in the emergency setting. Methods: A decision tree model was used to estimate the cost-effectiveness of HFNC compared with oxygen by nasal cannula (control strategy) in an infant with bronchiolitis in the emergency setting. Cost data were obtained from a retrospective study on bronchiolitis from tertiary centers in Rionegro, Colombia, while utilities were collected from the literature. Results:The QALYs per patient calculated in the base-case model were 0.9141 (95% CI 0.913- 0.915) in the HFNC and 0.9105 (95% CI 0.910- 0.911) in control group. The cost per patient was US$368 (95% CI US$ 323- 411) in HFNC and US$441 (95% CI US$ 384-498) per patient in the control group.Conclusions: HFNC in emergency settings was cost-effective for the hospital treatment of an infant with bronchiolitis

show abstract

Oxygen therapy with high-flow nasal cannulas in children with acute bronchiolitis

Cited by 7 publications

References 17 publications

Actualizacion De La Bronquiolitis Aguda

Actualizacion De La Bronquiolitis Aguda

The cost-utility of early use of high-flow nasal cannula in bronchiolitis

The Cost‑utility of Early use of High-flow Nasal Cannula in Bronchiolitis

Contact Info

Product

Resources

About